Health
STAT+: Are stem cells the next peptides? These advocates think RFK Jr. could make it happen
Publication: STAT
Author: Margaret Manto
Source published: 05/10/2026, 08:30:00 UTC
Briefing created: 05/10/2026, 08:38:18 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 05/10/2026, 08:36:24 UTC.
Briefings
Regenerative health entrepreneur Chuck Meeker predicts the FDA will soon host roundtables on stem cells, potentially legitimizing unapproved therapies. This follows the FDA's tentative embrace of compounded peptides, which Meeker views as a gateway for stem cells. The event occurred at a 2026 conference for regenerative health businesses, though the FDA declined to confirm if such roundtables are imminent.
Key points
- Regenerative health entrepreneur Chuck Meeker predicts the FDA will host roundtables on stem cells before the end of 2026, potentially legitimizing unapproved therapies.
- The event occurred at a 2026 conference for regenerative health businesses, though the FDA declined to confirm if such roundtables are imminent.
Context and limitations
The FDA declined to comment on the imminence of potential roundtables. Evidence is limited to a single quote from Meeker at a 2026 conference; no data on specific dates, numbers, or outcomes is available.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 05/10/2026, 08:38:18 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeidelzihoh5oa6caqpzcejmvykedgwhd4mghrigua2lnrnyv2hprpi